Published in J Cell Biochem on April 15, 2005
Post-translationally modified residues of native human osteopontin are located in clusters: identification of 36 phosphorylation and five O-glycosylation sites and their biological implications. Biochem J (2005) 1.69
Role of the metastasis-promoting protein osteopontin in the tumour microenvironment. J Cell Mol Med (2010) 1.53
Enhanced cell surface CD44 variant (v6, v9) expression by osteopontin in breast cancer epithelial cells facilitates tumor cell migration: novel post-transcriptional, post-translational regulation. Clin Exp Metastasis (2006) 1.26
Pre- and post-translational regulation of osteopontin in cancer. J Cell Commun Signal (2011) 1.17
Role of osteopontin in systemic lupus erythematosus. Arch Immunol Ther Exp (Warsz) (2014) 0.88
Phosphorylation of osteopontin in osteoarthritis degenerative cartilage and its effect on matrix metalloprotease 13. Rheumatol Int (2012) 0.85
Expression of osteopontin in oesophageal squamous cell carcinoma. Br J Cancer (2006) 0.83
Select nutrients, progesterone, and interferon tau affect conceptus metabolism and development. Ann N Y Acad Sci (2012) 0.81
ACP5 (Uteroferrin): phylogeny of an ancient and conserved gene expressed in the endometrium of mammals. Biol Reprod (2012) 0.78
Phosphorylation of osteopontin has proapoptotic and proinflammatory effects on human knee osteoarthritis chondrocytes. Exp Ther Med (2016) 0.75
Quantifying the biomechanics of conception: L-selectin-mediated blastocyst implantation mechanics with engineered "trophospheres". Tissue Eng Part A (2013) 0.75
Osteopontin activates mesenchymal stem cells to repair skin wound. PLoS One (2017) 0.75
A Potent Tartrate Resistant Acid Phosphatase Inhibitor to Study the Function of TRAP in Alveolar Macrophages. Sci Rep (2017) 0.75
Osteopontin at the Crossroads of Inflammation and Tumor Progression. Mediators Inflamm (2017) 0.75
A promoter-level mammalian expression atlas. Nature (2014) 6.25
Efficient mapping of mendelian traits in dogs through genome-wide association. Nat Genet (2007) 5.99
A regulatory mutation in IGF2 causes a major QTL effect on muscle growth in the pig. Nature (2003) 5.41
Targeted deletion of Klotho in kidney distal tubule disrupts mineral metabolism. J Am Soc Nephrol (2012) 2.48
Duplication of FGF3, FGF4, FGF19 and ORAOV1 causes hair ridge and predisposition to dermoid sinus in Ridgeback dogs. Nat Genet (2007) 2.33
Retracted Tunable plasmonic nanoprobes for theranostics of prostate cancer. Theranostics (2011) 1.73
Changes in gene expression during the early to mid-luteal (receptive phase) transition in human endometrium detected by high-density microarray screening. Mol Hum Reprod (2002) 1.71
Genome-wide analysis in German shepherd dogs reveals association of a locus on CFA 27 with atopic dermatitis. PLoS Genet (2013) 1.69
ZBED6, a novel transcription factor derived from a domesticated DNA transposon regulates IGF2 expression and muscle growth. PLoS Biol (2009) 1.61
beta2-microglobulin is a signaling and growth-promoting factor for human prostate cancer bone metastasis. Cancer Res (2006) 1.55
MUC1: a multifunctional cell surface component of reproductive tissue epithelia. Reprod Biol Endocrinol (2004) 1.52
Genome-wide association mapping identifies multiple loci for a canine SLE-related disease complex. Nat Genet (2010) 1.49
Hyaluronic acid-based hydrogels as 3D matrices for in vitro evaluation of chemotherapeutic drugs using poorly adherent prostate cancer cells. Biomaterials (2009) 1.37
Tumor necrosis factor-alpha converting enzyme/ADAM 17 mediates MUC1 shedding. J Biol Chem (2002) 1.36
MT1-MMP mediates MUC1 shedding independent of TACE/ADAM17. Biochem J (2004) 1.32
Potential role for heparan sulfate proteoglycans in regulation of transforming growth factor-beta (TGF-beta) by modulating assembly of latent TGF-beta-binding protein-1. J Biol Chem (2007) 1.32
Modeling Ewing sarcoma tumors in vitro with 3D scaffolds. Proc Natl Acad Sci U S A (2013) 1.23
Heparanase degrades syndecan-1 and perlecan heparan sulfate: functional implications for tumor cell invasion. J Biol Chem (2003) 1.23
Modulation of differentiation and mineralization of marrow stromal cells cultured on biomimetic hydrogels modified with Arg-Gly-Asp containing peptides. J Biomed Mater Res A (2004) 1.22
Multifunctionality of extracellular and cell surface heparan sulfate proteoglycans. Cell Mol Life Sci (2009) 1.22
Synergistic stimulation of MUC1 expression in normal breast epithelia and breast cancer cells by interferon-gamma and tumor necrosis factor-alpha. J Cell Biochem (2002) 1.20
Perlecan--a multifunctional extracellular proteoglycan scaffold. Glycobiology (2007) 1.19
The in vivo performance of plasmonic nanobubbles as cell theranostic agents in zebrafish hosting prostate cancer xenografts. Biomaterials (2010) 1.18
Osteogenic differentiation of rat bone marrow stromal cells cultured on Arg-Gly-Asp modified hydrogels without dexamethasone and beta-glycerol phosphate. Biomaterials (2005) 1.17
Global growth deficiencies in mice lacking the ribosomal protein HIP/RPL29. Dev Dyn (2007) 1.15
Intracellular machinery for matrix degradation in bone-resorbing osteoclasts. J Bone Miner Res (2004) 1.15
Differential expression of osteopontin and bone sialoprotein in bone metastasis of breast and prostate carcinoma. Clin Exp Metastasis (2003) 1.13
Attachment, proliferation, and migration of marrow stromal osteoblasts cultured on biomimetic hydrogels modified with an osteopontin-derived peptide. Biomaterials (2004) 1.13
Hyaluronic Acid-Based Hydrogels: from a Natural Polysaccharide to Complex Networks. Soft Matter (2012) 1.12
Osteoclasts from mice deficient in tartrate-resistant acid phosphatase have altered ruffled borders and disturbed intracellular vesicular transport. Exp Cell Res (2002) 1.11
R-Ras regulates migration through an interaction with filamin A in melanoma cells. PLoS One (2010) 1.11
Evaluation of cross-linking methods for electrospun gelatin on cell growth and viability. Biomacromolecules (2009) 1.10
Chondrogenic activity of the heparan sulfate proteoglycan perlecan maps to the N-terminal domain I. J Bone Miner Res (2002) 1.09
Elucidation of estrogen receptor function in bone with the use of mouse models. Trends Endocrinol Metab (2002) 1.08
Chondrogenic differentiation on perlecan domain I, collagen II, and bone morphogenetic protein-2-based matrices. Tissue Eng (2006) 1.06
Perlecan domain I-conjugated, hyaluronic acid-based hydrogel particles for enhanced chondrogenic differentiation via BMP-2 release. Biomaterials (2009) 1.05
Proteolytic excision of a repressive loop domain in tartrate-resistant acid phosphatase by cathepsin K in osteoclasts. J Biol Chem (2005) 1.05
Perlecan knockdown in metastatic prostate cancer cells reduces heparin-binding growth factor responses in vitro and tumor growth in vivo. Clin Exp Metastasis (2005) 1.05
Association of the α(2)δ(1) subunit with Ca(v)3.2 enhances membrane expression and regulates mechanically induced ATP release in MLO-Y4 osteocytes. J Bone Miner Res (2011) 1.03
Progesterone receptor isoforms A and B differentially regulate MUC1 expression in uterine epithelial cells. Mol Endocrinol (2006) 1.03
Novel surface expression of reticulocalbin 1 on bone endothelial cells and human prostate cancer cells is regulated by TNF-alpha. J Cell Biochem (2008) 1.02
Repression of HIP/RPL29 expression induces differentiation in colon cancer cells. J Cell Physiol (2006) 1.01
Conditional disruption of calcineurin B1 in osteoblasts increases bone formation and reduces bone resorption. J Biol Chem (2007) 1.01
Resveratrol prevents RANKL-induced osteoclast differentiation of murine osteoclast progenitor RAW 264.7 cells through inhibition of ROS production. Biochem Biophys Res Commun (2010) 1.01
Nuclear translocation of the 1,25D3-MARRS (membrane associated rapid response to steroids) receptor protein and NFkappaB in differentiating NB4 leukemia cells. Exp Cell Res (2010) 1.00
Quantitative modeling and analysis of the transforming growth factor beta signaling pathway. Biophys J (2009) 1.00
Fiber diameters control osteoblastic cell migration and differentiation in electrospun gelatin. J Biomed Mater Res A (2010) 1.00
Hierarchically structured, hyaluronic acid-based hydrogel matrices via the covalent integration of microgels into macroscopic networks. Soft Matter (2010) 0.99
Formation of MUC1 metabolic complex is conserved in tumor-derived and normal epithelial cells. Biochem Biophys Res Commun (2002) 0.99
MHC class II polymorphism is associated with a canine SLE-related disease complex. Immunogenetics (2009) 0.99
Heparan sulfate proteoglycans: key players in cartilage biology. Crit Rev Eukaryot Gene Expr (2005) 0.98
Perlecan/Hspg2 deficiency alters the pericellular space of the lacunocanalicular system surrounding osteocytic processes in cortical bone. J Bone Miner Res (2011) 0.98
Tumor necrosis factor alpha stimulates MUC1 synthesis and ectodomain release in a human uterine epithelial cell line. Endocrinology (2004) 0.98
ZBED evolution: repeated utilization of DNA transposons as regulators of diverse host functions. PLoS One (2013) 0.98
Lumen formation in three-dimensional cultures of salivary acinar cells. Otolaryngol Head Neck Surg (2010) 0.98
Recreating the tumor microenvironment in a bilayer, hyaluronic acid hydrogel construct for the growth of prostate cancer spheroids. Biomaterials (2012) 0.96
Biofunctionalization of electrospun PCL-based scaffolds with perlecan domain IV peptide to create a 3-D pharmacokinetic cancer model. Biomaterials (2010) 0.96
Coating electrospun collagen and gelatin fibers with perlecan domain I for increased growth factor binding. Biomacromolecules (2007) 0.95
TRACP as an osteopontin phosphatase. J Bone Miner Res (2003) 0.94
Differentiation-induced loss of heparan sulfate in human exostosis derived chondrocytes. Differentiation (2005) 0.94
Cholesterol-sensing receptors, liver X receptor alpha and beta, have novel and distinct roles in osteoclast differentiation and activation. J Bone Miner Res (2006) 0.94
ZBED6: The birth of a new transcription factor in the common ancestor of placental mammals. Transcription (2010) 0.94
Improved cellular specificity of plasmonic nanobubbles versus nanoparticles in heterogeneous cell systems. PLoS One (2012) 0.94
Osteoclast migration on phosphorylated osteopontin is regulated by endogenous tartrate-resistant acid phosphatase. Exp Cell Res (2009) 0.94
Interleukin-6: a bone marrow stromal cell paracrine signal that induces neuroendocrine differentiation and modulates autophagy in bone metastatic PCa cells. Autophagy (2012) 0.94
Nicotinamide phosphoribosyltransferase (Nampt) affects the lineage fate determination of mesenchymal stem cells: a possible cause for reduced osteogenesis and increased adipogenesis in older individuals. J Bone Miner Res (2011) 0.93
RANK- and c-Met-mediated signal network promotes prostate cancer metastatic colonization. Endocr Relat Cancer (2014) 0.93
The first sequenced carnivore genome shows complex host-endogenous retrovirus relationships. PLoS One (2011) 0.92
Paracrine factors produced by bone marrow stromal cells induce apoptosis and neuroendocrine differentiation in prostate cancer cells. Prostate (2011) 0.92
A novel peptide sequence in perlecan domain IV supports cell adhesion, spreading and FAK activation. Matrix Biol (2007) 0.92
Implantable three-dimensional salivary spheroid assemblies demonstrate fluid and protein secretory responses to neurotransmitters. Tissue Eng Part A (2013) 0.92
Heparan sulfate proteoglycans: coordinators of multiple signaling pathways during chondrogenesis. Birth Defects Res C Embryo Today (2004) 0.92
Monomeric tartrate resistant acid phosphatase induces insulin sensitive obesity. PLoS One (2008) 0.92
Two loci on chromosome 5 are associated with serum IgE levels in Labrador retrievers. PLoS One (2012) 0.92
Osteoprotegerin expression and secretion are regulated by calcium influx through the L-type voltage-sensitive calcium channel. Endocrinology (2003) 0.91
High extracellular calcium attenuates adipogenesis in 3T3-L1 preadipocytes. Exp Cell Res (2004) 0.91
Hypoxia increases VEGF-A production by prostate cancer and bone marrow stromal cells and initiates paracrine activation of bone marrow endothelial cells. Clin Exp Metastasis (2006) 0.91
Mucins and blastocyst attachment. Rev Endocr Metab Disord (2002) 0.91
Ribosomal protein L29/HIP deficiency delays osteogenesis and increases fragility of adult bone in mice. J Orthop Res (2009) 0.91
Polarization and secretion of cathepsin K precede tartrate-resistant acid phosphatase secretion to the ruffled border area during the activation of matrix-resorbing clasts. J Bone Miner Metab (2005) 0.90
Perlecan domain IV peptide stimulates salivary gland cell assembly in vitro. Tissue Eng Part A (2009) 0.90
Microfabricated electrospun collagen membranes for 3-D cancer models and drug screening applications. Biomacromolecules (2009) 0.90
Injectable perlecan domain 1-hyaluronan microgels potentiate the cartilage repair effect of BMP2 in a murine model of early osteoarthritis. Biomed Mater (2012) 0.89
Identification and characterization of 1,25D3-membrane-associated rapid response, steroid (1,25D3-MARRS) binding protein. J Steroid Biochem Mol Biol (2004) 0.89
Perlecan-containing pericellular matrix regulates solute transport and mechanosensing within the osteocyte lacunar-canalicular system. J Bone Miner Res (2014) 0.89
Vitamin a is a negative regulator of osteoblast mineralization. PLoS One (2013) 0.89
Decidual differentiation of stromal cells promotes Proprotein Convertase 5/6 expression and lefty processing. Endocrinology (2005) 0.89
HIP/RPL29 down-regulation accompanies terminal chondrocyte differentiation. Differentiation (2003) 0.89